| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_18726312eff9eb2bd2f380dd8189ec20 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-59 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-59
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-573 |
| filingDate |
2005-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d7ab6ca7645273b82c55d63a04c5cdb |
| publicationDate |
2006-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AR-049517-A1 |
| titleOfInvention |
USE OF A PHARMACEUTICAL COMPOSITION THAT INCLUDES CALCITRIOL AND CLOBETASOL PROPIONATE FOR THE TREATMENT OF PSORIASIS AND SUCH COMPOSITION |
| abstract |
A pharmaceutical composition for the treatment of psoriasis, characterized in that it comprises clobetasol propionate and calcitriol, in an appropriate amount for an application once a day on the part (s) of the skin (s) affected by psoriasis. |
| priorityDate |
2004-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |